Palabras clave
Equilibrio
Marcha
Cuidados de salud
Impacto psicosocial
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Verificar el comportamiento de los síntomas depresivos, fatiga, equilibrio postural y marcha en mujeres con Esclerosis Múltiple (EM), antes del aislamiento y después del fin del aislamiento social, medida introducida por la pandemia de Covid-19. Métodos: La muestra de este estudio longitudinal prospectivo incluyó a 15 mujeres con EM. Utilizando la Escala de Enfermedad Determinada por el Paciente (PDDS), categorizamos dos grupos, sin discapacidad para caminar (GSI) y con discapacidad (GCI). Se evaluó, en dos momentos, la presencia de síntomas depresivos mediante el inventario de Beck (BECK-II), la gravedad de la fatiga (FSS) y su impacto (MFIS), el equilibrio postural (posturografía) y la marcha (test de marcha de 25 pies). Para comparar las variables recogidas en diferentes momentos se utilizó una prueba t pareada. Resultados: Encontramos mejoras significativas y un tamaño del efecto moderado (p<0,05 y ES>0,50) en los síntomas depresivos y la fatiga del GCI después del final del aislamiento. No encontramos diferencias significativas en las otras comparaciones. Conclusión: Como hallazgo principal, nuestro estudio mostró que para el GCI, regresar a la vida social fue suficiente para una mejora significativa en los síntomas depresivos y la fatiga. Por tanto, reforzamos la importancia de la atención sanitaria dirigida al ámbito psicosocial en la población de mujeres con EM e incapacidad para caminar.
Referencias
ALSCHULER KN, et al. Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic. Mult Scler Relat Disord., 2021; 47: 102618.
ALTUNAN B, et al. Coping with stress during the first wave of the COVID-19 pandemic by Turkish people with Multiple Sclerosis: The relationship between perceived stress and quality of life. Mult Scler Relat Disord., 2021; 53: 103039.
ANDREU-CARAVACA L, et al. The impact of COVID-19 home confinement on neuromuscular performance, functional capacity, and psychological state in Spanish people with Multiple Sclerosis. Mult Scler Relat Disord., 2021; 53: 103047.
BONAVITA S, et al. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic. Eur J Neurol., 2021; 28(10): 3396-3402.
CAPUANO R, et al. Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? J Neurol., 2021; 268(3): 743-750.
CAPUTO EL e REICHERT FF. Studies of Physical Activity and COVID-19 During the Pandemic: A Scoping Review. J Phys Act Health, 2020; 17(12): 1275-1284.
CHALAH MA, et al. Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation. Front Cell Neurosci., 2015; 9: 460.
CHIARAVALLOTI ND, et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J Neurol., 2021; 268(5): 1598-1607.
COHEN J. Statistical power analysis for the behavioral sciences Lawrence Earlbaum Associates. 20th–. Published online 1988.
COMPSTON A e COLES A. Multiple sclerosis. The Lancet, 2008; 372(9648): 1502-1517.
COSTABILE T, et al. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management. Eur J Neurol., 2021; 28(10): 3375-3383.
DONZÉ C e MASSOT C. Rehabilitation in multiple sclerosis in 2021. Presse Médicale, 2021; 50(2): 104066.
DOSHI A e CHATAWAY J. Multiple sclerosis, a treatable disease. Clin Med., 2017; 17(6): 530-536.
FEINSTEIN A, et al. The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study. J Neurol., 2022; 269(12): 6202-6210.
FIORILLO A, et al. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network. Eur Psychiatry J Assoc Eur Psychiatr., 2020; 63(1): e87.
FISCHER JS, et al. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler Houndmills Basingstoke Engl., 1999; 5(4): 244-250.
FISK JD, et al. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci J Can Sci Neurol., 1994; 21(1): 9-14.
GOMES-OLIVEIRA MH, et al. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr Sao Paulo Braz, 2012; 34(4): 389-394.
HOHOL MJ, et al. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology, 1995; 45(2): 251-255.
KOOPMANN A, et al. The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany. Eur Addict Res., 2021; 27(4): 242-256.
KURTZKE JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1983; 33(11): 1444-1452.
LEARMONTH YC, et al. Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci., 2013; 331(1-2): 102-107.
LEARMONTH YC, et al. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol., 2013; 13: 37.
LEE G e PARK AE. Development of a more robust tool for postural stability analysis of laparoscopic surgeons. Surg Endosc., 2008; 22(4): 1087-1092.
MORRIS-BANKOLE H e HO AK. The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral. Neurol Ther., 2021; 10(1): 279-291.
MOTL RW, et al. Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Res Nurs Health, 2006; 29(6): 597-606.
MOTOLESE F, et al. The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis. Front Neurol. 2020;11:580507.
PATEJDL R, et al. Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun Rev. 2016;15(3):210-220.
POLMAN CH, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
RAYMAKERS JA, et al. The assessment of body sway and the choice of the stability parameter(s). Gait Posture. 2005;21(1):48-58.
SACCO R, et al. Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol. 2016;23(4):744-750.
SCOPPA F, et al. Clinical stabilometry standardization: Basic definitions – Acquisition interval – Sampling frequency. Gait Posture. 2013;37(2):290-292.
SOLARO C, et al. Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment. CNS Drugs. 2018;32(2):117-133.
STOJANOV A, et al. Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord. 2020;45:102407.
THOMPSON AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
VAN EMMERIK REA, et al. Postural control in women with multiple sclerosis: effects of task, vision and symptomatic fatigue. Gait Posture. 2010;32(4):608-614.
VERCELLINO M, et al. Impact of COVID-19 lockdown on progressive multiple sclerosis patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2022;43(5):2943-2946.
WEILAND TJ, et al. Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet. PLOS ONE. 2015;10(2):e0115541.
WILSKI M, et al. Mental Health Status of People with Multiple Sclerosis during the COVID-19 Pandemic. J Clin Med. 2022;11(3):576.
ZANGHÌ A, et al. Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience. Mult Scler Relat Disord. 2020;46:102561.